In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1882-1885

  Moore, Caroline B ^a   Walls, Caroline M ^a,d   Denning, David W ^a,b,c  

^a HOPE HOSPITAL   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d HEALTH AND SAFETY EXECUTIVE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ITRACONAZOLE; TERBINAFINE;

ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; ASPERGILLUS ORYZAE; ASPERGILLUS TERREUS; DRUG EFFICACY; DRUG POTENCY; FUNGICIDAL ACTIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES;

EID: 0035018492     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1882-1885.2001     Document Type: Article

References (17)

1. Barchiesi, F., L. F. Di Francesco, P. Compagnucci, D. Arzeni, A. Giacometti, and G. Scalise. 1998. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J. Antimicrob. Chemother. 41:59-65.
2. Contini, C., M. Manganaro, R. Romani, S. Tzantzoglou, I. Poggesi, V. Vullo, S. Delia, and C. De Simone. 1994. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia. J. Antimicrob. Chemother. 34:727-735.
3. Denning, D. W., S. A. Radford, K. L. Oakley, L. Hall, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-414.
4. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-803.
5. Jessup, C. J., N. S. Ryder, and M. A. Ghannoum. 2000. An evaluation of the in vitro activity of terbinafine. Med. Mycol. 38:155-159.
6. Johnson, E. M., K. L. Oakley, S. A. Radford, C. B. Moore, P. Warn, D. W. Warnock, and D. W. Denning. 2000. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J. Antimicrob. Chemother. 45:85-93.
7. Kovarik, J. M., E. A. Mueller, H. Zehender, J. Denouël, H. Caplain, and L. Millerioux. 1995. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites. Antimicrob. Agents Chemother. 39:2738-2741.
8. Latgé, J.-P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
9. McGinnis, M. R., N. G. Nordoff, N. S. Ryder, and G. B. Nunn. 2000. In vitro comparison of terbinafine and itraconazole against Penicillium marneffei. Antimicrob. Agents Chemother. 44:1407-1408.
10. Meletiadis, J., J. W. Mouton, J. L. Rodriguez-Tudela, J. F. G. M. Meis, and P. E. Verweij. 2000. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob. Agents Chemother. 44:470-472.
11. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M-38P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Ryder, N. S., S. Wagner, and I. Leitner. 1998. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob. Agents Chemother. 42:1057-1061.
13. Schiraldi, G. F., S. Lo Cicero, M. D. Colombo, D. Rossato, M. Ferrarese, and E. Soresi. 1996. Refractory pulmonary aspergillosis: compassionate trial with terbinafine. Br. J. Dermatol. 134(Suppl. 46):25-29.
14. Schmitt, H. J., E. M. Bernard, J. Andrade, F. Edwards, B. Schmitt, and D. Armstrong. 1988. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 32:780-781.
15. Torres-Rodríguez, J. M., N. Madrenys-Brunet, M. Siddat, O. López-Jodra, and T. Jimenez. 1998. Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs. J. Eur. Acad. Dermatol. Venereol. 11:25-31.
16. Verweij, P. E., M. F. Q. van den Bergh, P. M. Rath, B. E. de Pauw, A. Voss, and J. F. G. M. Meis. 1999. Invasive aspergillosis caused by Aspergillus ustus: case report and review. J. Clin. Microbiol. 37:1606-1609.
17. Vogeser, M., A. Wanders, A. Haas, and G. Ruckdeschel. 1999. A four-year review of fatal aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 18:42-45.